Leaderboards/Glioma Diagnosis and Treatment

Glioma Diagnosis and Treatment

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Nourhan Abdelfattah
Houston Methodist
2
Daan J. Kloosterman
Oncode Institute
3
Sarthak Pati
Heidelberg University
4
Leire Bejarano
University Hospital of Lausanne
5
Ester Gangoso
Edinburgh Cancer Research
6
Chen Chen
Fudan University Shanghai Cancer Center
7
Bader Aldughayfiq
Jouf University
8
Carlo Vermeulen
Utrecht University
9
Emmet Huang-Hobbs
Memorial Sloan Kettering Cancer Center
10
Lisa Mayr
Comprehensive Cancer Center Vienna

Papers

1
Macrophage-mediated myelin recycling fuels brain cancer malignancy
Cell|2024
187 cit.
2
Publication in Cancer Cell (2024) [80 citations, W4391056102]
Cancer Cell|2024
80 cit.
3
Effective targeting of PDGFRA-altered high-grade glioma with avapritinib
Cancer Cell|2025
41 cit.
4
Publication in Immunity (2025) [28 citations, W4408572842]
Immunity|2025
28 cit.
5
Publication in STAR Protocols (2024) [4 citations, W4404004459]
STAR Protocols|2024
4 cit.
6
Layer-Weighted Attention and Ascending Feature Selection: An Approach for Seriousness Level Prediction Using the FDA Adverse Event Reporting System
Applied Sciences|2024
3 cit.
7
IMMU-64. SEX-SPECIFIC ROLES OF<i>YAP1</i> AND CD276/B7-H3 IN MEDULLOBLASTOMA IMMUNE SUPPRESSION
Neuro-Oncology|2024
1 cit.
8
Correlation of TP53 Genetic Alterations with p53 Immunohistochemical Expression and Their Prognostic Significance in DLBCL
Current Oncology|2025
1 cit.
9
Publication in International Journal of Distributed Sensor Networks (2025) [1 citation, W4414128077]
International Journal of Distributed Sensor Networks|2025
1 cit.
10
Publication in Cancer Research (2024) [W4393072869]
Cancer Research|2024
0 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Donghui Tan
Jiangxi College of Applied Technology
2
Vijay Ramaswamy
Hospital for Sick Children
3
David R. Raleigh
University of California, San Francisco
4
Qixue Wang
Tianjin Medical University General Hospital
5
Zhaoshi Bao
Beijing Tian Tan Hospital
6
Shona Nag
Max Super Speciality Hospital
7
Nathalie L. Albert
LMU Klinikum
8
Sriram Venneti
University of Michigan
9
Carl Koschmann
University of Michigan
10
Volker Hovestadt
Broad Institute

Papers

1
Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities
Nature Genetics|2022
302 cit.
2
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
Cancer Discovery|2023
154 cit.
3
Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma
Neuro-Oncology|2022
122 cit.
4
Conumee 2.0: enhanced copy-number variation analysis from DNA methylation arrays for humans and mice
Bioinformatics|2024
113 cit.
5
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses
Nature Medicine|2023
106 cit.
6
ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitization
Cell Reports|2022
76 cit.
7
Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features
Neuro-Oncology|2022
71 cit.
8
PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma
Frontiers in Immunology|2022
66 cit.
9
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0
European Journal of Nuclear Medicine and Molecular Imaging|2024
62 cit.
10
Encapsulation of Platinum Prodrugs into PC7A Polymeric Nanoparticles Combined with Immune Checkpoint Inhibitors for Therapeutically Enhanced Multimodal Chemotherapy and Immunotherapy by Activation of the STING Pathway
Advanced Science|2022
61 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Jill S. Barnholtz‐Sloan
Emory University
2
Jeremy N. Rich
University of North Carolina at Chapel Hill
3
Andreas von Deimling
German Cancer Research Center
4
Stefan M. Pfister
Heidelberg University
5
Michael Weller
University Hospital of Zurich
6
Roger Stupp
Northwestern University
7
Darell D. Bigner
Duke Medical Center
8
Timothy F. Cloughesy
University of California, Los Angeles
9
Mitchel S. Berger
University of California, San Francisco
10
Minesh P. Mehta
Columbia University

Papers

1
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
New England Journal of Medicine|2005
21.6k cit.
2
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
Neuro-Oncology|2013
12.1k cit.
3
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
The Lancet Oncology|2009
7.8k cit.
4
<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma
New England Journal of Medicine|2005
7.3k cit.
5
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Nature|2006
6.4k cit.
6
<i>IDH1</i>and<i>IDH2</i>Mutations in Gliomas
New England Journal of Medicine|2009
5.9k cit.
7
DNA methylation-based classification of central nervous system tumours
Nature|2018
3.1k cit.
8
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
New England Journal of Medicine|2014
2.8k cit.
9
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
Neuro-Oncology|2019
2.6k cit.
10
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
JAMA|2017
2.6k cit.

Reagents for Glioma Diagnosis and Treatment

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 67

Myeloperoxidase (E2Z8J) Rabbit Monoclonal Antibody

Cited in 17 papers
#15178$175,376
View Evidence →
Cell Signaling TechnologyEvidence 64

PathScan® Phospho-4E-BP1 (Thr37/Thr46) Sandwich ELISA Kit

Cited in 15 papers
#7216$66,129,740
View Evidence →
Cell Signaling TechnologyEvidence 67

IMP3 (D6U2N) Rabbit Monoclonal Antibody

Cited in 13 papers
#57145$161,351
View Evidence →

🌟 All-Time

Most validated

Millipore

Anti-Histone H3.3 Antibody, K27M mutant

Cited in 35 papers
#ABE419
View Evidence →
Cell Signaling Technology

0.5 M EDTA, pH 8.0

Cited in 25 papers
#7011$42
View Evidence →
Agilent/Dako

Glial Fibrillary Acidic Protein (GFAP)

Cited in 18 papers
#M0761
View Evidence →